Phase I study of camrelizumab in patients with advanced solid tumors.
2023
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.
UI
MeSH Term
Description
Entries
D009369
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D061067
Antibodies, Monoclonal, Humanized
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Antibodies, Humanized,Humanized Antibodies
Related Publications
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
December 2005,
American journal of clinical oncology,
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
September 2002,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang
March 2002,
Clinical cancer research : an official journal of the American Association for Cancer Research,
Yuxiang Ma, and
Jiaxin Cao, and
Yang Zhang, and
Qianwen Liu, and
Wenfeng Fang, and
Yunpeng Yang, and
Yuanyuan Zhao, and
Qing Yang, and
Hongyun Zhao, and
Li Zhang